You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,182,838


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,182,838
Title:Dry powder composition comprising co-jet milled particles for pulmonary inhalation
Abstract: The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active particles comprising a pharmaceutically active material for pulmonary inhalation, the method comprising a jet milling process.
Inventor(s): Morton; David (Chippenham, GB), Staniforth; John (Chippenham, GB)
Assignee: Vectura Limited (Chippenham, GB)
Application Number:10/571,146
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,182,838

Introduction

United States Patent 8,182,838, titled "Dry powder composition comprising co-jet milled particles for pulmonary inhalation," is a significant patent in the field of pharmaceuticals and drug delivery systems. This patent, granted on May 22, 2012, pertains to the development of dry powder compositions designed for pulmonary inhalation, which is crucial for the treatment of various respiratory diseases.

Background

The patent addresses the need for efficient and stable dry powder formulations that can be effectively delivered to the lungs. The invention involves the use of co-jet milling, a process that enhances the physical and chemical properties of the particles, making them more suitable for inhalation.

Patent Scope

The scope of a patent is a critical aspect that defines the boundaries of the invention and what is protected under the patent. Here are some key points regarding the scope of US Patent 8,182,838:

Independent Claims

The patent includes several independent claims that define the core of the invention. These claims typically describe the composition, the method of making the composition, and the use of the composition for pulmonary inhalation. For instance, Claim 1 might describe the dry powder composition comprising co-jet milled particles, while Claim 2 might detail the method of preparing these particles[1].

Claim Length and Count

Research on patent scope often involves analyzing the length and count of independent claims. Studies have shown that narrower claims, both in terms of length and count, are associated with a higher probability of grant and a shorter examination process. This suggests that the claims in US Patent 8,182,838 were likely refined during the examination process to ensure clarity and specificity[3].

Claim Construction

Claim construction is the process of interpreting the meaning of the claims in a patent. This is crucial for determining the scope of protection and for litigation purposes.

Federal Circuit Guidelines

The Federal Circuit has established guidelines for claim construction, which include the principles outlined in cases such as Nautilus, Inc. v. Biosig Instruments, Inc.. These guidelines emphasize the importance of clear and definite claim language to avoid ambiguity and ensure that the claims are not overly broad[5].

Examiner's Role

During the patent examination process, the examiner plays a significant role in ensuring that the claims are clear, concise, and do not encompass subject matter that is not disclosed in the specification. The examiner must classify the invention information and ensure that the primary classification aligns with the main inventive concept of the application[4].

Patent Claims Analysis

Claim Language

The claims in US Patent 8,182,838 are written to describe the specific characteristics of the dry powder composition and the process of co-jet milling. The language used is precise to ensure that the scope of the invention is well-defined and distinguishable from prior art.

Dependency Relationship

The dependency relationship between claims is another important aspect. In this patent, dependent claims may further limit the scope of the independent claims by adding additional features or requirements. This helps in narrowing down the invention to its most essential elements[2].

Patent Landscape

Classification

The patent is classified under the relevant subclasses of the United States Patent Classification (USPC) system. This classification helps in organizing and searching for patents within the same technological field. The primary classification is assigned based on the main inventive concept, while secondary classifications are assigned for additional invention information[4].

Forward Citations

Forward citations, which are citations to the patent by later patents, can indicate the impact and relevance of the invention. A higher number of forward citations often suggests that the patent is influential and has contributed significantly to the field.

Maintenance Payments

The maintenance payments for a patent can also reflect its scope and importance. Patents with narrower claims tend to have lower maintenance costs and are more likely to be maintained over their full term, indicating their continued relevance and value[3].

Economic and Innovation Impact

Innovation Incentives

The scope and claims of a patent can significantly influence innovation incentives. Patents with clear and well-defined claims can reduce licensing and litigation costs, thereby encouraging further innovation in the field.

Market Dominance

A patent with a well-defined scope can provide a competitive advantage, allowing the patent holder to dominate the market for the specific technology. In the case of US Patent 8,182,838, the clear definition of the dry powder composition and its method of preparation could give the patent holder a significant edge in the pharmaceutical market.

Legal and Regulatory Considerations

Litigation Risks

The clarity and specificity of the claims in US Patent 8,182,838 can mitigate litigation risks. Overly broad or ambiguous claims can lead to disputes and legal challenges, which can be costly and time-consuming.

Regulatory Compliance

The patent must comply with regulatory requirements, especially in the pharmaceutical industry. The claims and scope of the patent must align with FDA regulations and other relevant standards to ensure the safety and efficacy of the product.

Conclusion

US Patent 8,182,838 is a significant contribution to the field of pharmaceuticals, particularly in the development of dry powder compositions for pulmonary inhalation. The patent's scope and claims are carefully defined to ensure clarity and specificity, which is crucial for both legal and practical purposes.

Key Takeaways

  • Clear Claim Language: The patent's claims are written to be precise and clear, avoiding ambiguity.
  • Narrow Claims: The claims are refined to ensure a higher probability of grant and shorter examination process.
  • Classification: The patent is classified under relevant subclasses of the USPC system.
  • Innovation Impact: The patent's scope can influence innovation incentives and reduce licensing and litigation costs.
  • Market Dominance: A well-defined scope can provide a competitive advantage in the market.
  • Legal and Regulatory Compliance: The patent must comply with regulatory requirements and avoid litigation risks.

FAQs

Q: What is the main invention described in US Patent 8,182,838? A: The main invention is a dry powder composition comprising co-jet milled particles for pulmonary inhalation.

Q: Why is claim construction important in patent law? A: Claim construction is crucial for determining the scope of protection and for litigation purposes, ensuring that the claims are clear and not overly broad.

Q: How does the patent classification system work? A: The patent is classified under the USPC system, with primary and secondary classifications assigned based on the main inventive concept and additional invention information.

Q: What is the impact of forward citations on a patent? A: Forward citations indicate the influence and relevance of the patent, with higher citations suggesting greater impact.

Q: How can a well-defined patent scope affect innovation? A: A well-defined patent scope can reduce licensing and litigation costs, thereby encouraging further innovation in the field.

Sources

  1. US8182838B2 - Dry powder composition comprising co-jet milled particles for pulmonary inhalation - Google Patents
  2. Patent Claims Research Dataset - USPTO
  3. Patent Claims and Patent Scope - SSRN
  4. Patent Analysis for Placement into System (Claimed Disclosure) - USPTO
  5. Patent Claim Construction in the Federal Circuit, 2024 ed - Thomson Reuters

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,182,838

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novartis SEEBRI glycopyrrolate POWDER;INHALATION 207923-001 Oct 29, 2015 DISCN Yes No 8,182,838 ⤷  Subscribe Y ⤷  Subscribe
Novartis UTIBRON glycopyrrolate; indacaterol maleate POWDER;INHALATION 207930-001 Oct 29, 2015 DISCN Yes No 8,182,838 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,182,838

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0321607.4Sep 15, 2003
PCT Information
PCT FiledSeptember 15, 2004PCT Application Number:PCT/GB2004/003996
PCT Publication Date:March 24, 2005PCT Publication Number: WO2005/025536

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.